Last reviewed · How we verify
Prototype capsule GDC-0134 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Prototype capsule GDC-0134 (Prototype capsule GDC-0134) — Genentech, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prototype capsule GDC-0134 TARGET | Prototype capsule GDC-0134 | Genentech, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prototype capsule GDC-0134 CI watch — RSS
- Prototype capsule GDC-0134 CI watch — Atom
- Prototype capsule GDC-0134 CI watch — JSON
- Prototype capsule GDC-0134 alone — RSS
Cite this brief
Drug Landscape (2026). Prototype capsule GDC-0134 — Competitive Intelligence Brief. https://druglandscape.com/ci/prototype-capsule-gdc-0134. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing